Source: Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Bulgakova, E. Surkova, T. Ses, G. Aleshina, T. Sologub, E. Boitsova, T. Gembitskaia (Saint-Petersburg, Russia). Myeloperoxidase and lactoferrin in serum of children with exacerbation of cystic fibrosis. Eur Respir J 2001; 16: Suppl. 31, 856

Member's Comments

No comment yet.

Related content which might interest you: Serum bactericidal activity in non cystic fibrosis bronchiectasis in patients with pseudomonas aeruginosa colonisation Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 KL-6 serum levels in adult cystic fibrosis patients Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011 Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis Source: Eur Respir J, 51 (3) 1701910; 10.1183/13993003.01910-2017 Year: 2018 Serum lipid concentrations and malnutrition in adult cystic fibrosis patients Source: Eur Respir J 2006; 28: Suppl. 50, 58s Year: 2006 Vitamin D serum level and pulmonary exacerbations in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Arginase in patients with cystic fibrosis airway disease Source: Annual Congress 2004 - Cystic fibrosis in the 21st century: cutting edge investigations, taxing problems Year: 2004 Myeloperoxidase oxidation of methionine associates with early cystic fibrosis lung disease Source: Eur Respir J, 52 (4) 1801118; 10.1183/13993003.01118-2018 Year: 2018 α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients Source: Eur Respir J 2007; 29: 240-250 Year: 2007 Sputum biomarkers of inflammatory in children with cystic fibrosis Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Sputum biomarkers of inflammatory in children with cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: advances in clinical research Year: 2009 Sputum and plasma neutrophil elastase in stable adult patients with cystic fibrosis in relation to chronic Pseudomonas colonization. Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Neutrophilic inflammation predisposes to structural lung disease in cystic fibrosis (CF) via neutrophil elastase activity Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies Year: 2009 Airway bacterial colonization is associated with low vitamin D serum levels in children with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 Serum progranulin levels in idiopathic pulmonary fibrosis and other interstitial lung diseases Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 ECP and EPX in bronchoalveolar lavage fluid in children with cystic fibrosis and mild lung disease Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001 Serum chitotriosidase levels in granulomatous lung disorders Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Overexpression of chitotriosidase and YKL-40 in serum and sputum in healthy smokers and patients with  chronic obstructive pulmonary disease Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018 Sputum bacterial concentrations and exacerbations of non cystic fibrosis bronchiectasis Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Neutrophil elastase and lung damage in cystic fibrosis Source: International Congress 2018 – Proteases: at the cutting edge of lung disease Year: 2018